BDTX - Company ID 0001701541
The table below shows Black Diamond Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.19M | $30.07M | $30.86M | $29.99M | $98.42M | $23.43M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $115.39M |
| $122.97M |
| $138.99M |
| $146.73M |
| $155.68M |
| $115.54M |
| Property, plant & equipment | $310.00K | $338.00K | $1.13M | $1.21M | $1.30M | $1.47M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $125.03M | $132.92M | $157.73M | $166.38M | $176.25M | $137.90M |
| Accounts payable | $1.40M | $2.97M | $975.00K | $771.00K | $2.63M | $1.97M |
| Total current liabilities | $15.84M | $14.53M | $15.54M | $16.80M | $16.85M | $20.80M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $28.94M | $28.62M | $31.58M | $33.77M | $34.73M | $40.47M |
| Retained earnings | -$483.68M | -$473.78M | -$449.62M | -$441.13M | -$430.56M | -$471.12M |
| Total equity | $96.09M | $104.30M | $126.15M | $132.61M | $141.52M | $97.43M |